Please watch this video and answer the following questions. Your responses are anonymous. By answering these questions, you are participating in asthma research! Research helps experts better understand asthma. It also helps them develop better treatments. This video explains what research is and its benefits. Watch video on YouTube Watch the next video in this series - Finding Accurate Research Information
About 25 million Americans have asthma. There is no cure. But you can manage it with a proper treatment plan and by avoiding triggers. But there might be one thing out of your control that can make managing asthma a challenge: where you live. Today, the Asthma and Allergy Foundation of America (AAFA) has released the 2018 Asthma Capitals™ report. This report ranks the top 100 cities in the U.S. where it’s challenging to live with asthma.
The Asthma and Allergy Foundation of America (AAFA) has released the 2019 Spring Allergy Capitals™ report to look at why some locations are more affected than others. Our report ranks the top 100 cities in the nation for spring allergies.
Atopic dermatitis (AD) is a chronic condition where your skin becomes dry and itchy too easily. This can lead to allergies and inflammation. It is more common in children than adults. But current research suggests that more adults may have it than once thought. AD is also sometimes called eczema. There is no cure.
The Asthma and Allergy Foundation of America (AAFA) joined with Allergy Standards Limited (ASL) to create the asthma & allergy friendly® Certification Program. This program helps people make informed purchases for a healthier home. We test household products against strict standards. If products pass our tests, they earn the asthma & allergy friendly® mark.
If you are one of the 50 million Americans living with allergies, you’re probably familiar with the tell-tale signs of allergies, such as sneezing, itchy nose, and watery eyes. But do you know what causes these symptoms? Let’s start at the beginning. An allergy is a disease of the immune system. The body’s immune system receives input from the environment and produces a response. Its purpose is to recognize and attack foreign invaders, such as bacteria and parasites. An allergy occurs when...
People with asthma have more treatment choices than ever before, and the FDA recently announced approval for the readmittance of Primatene Mist – an over-the-counter (OTC) epinephrine inhaler. The Asthma and Allergy Foundation of America (AAFA) cautions patients to not stop their current asthma treatment nor start taking this OTC option without talking to their health care provider first.
FOR IMMEDIATE RELEASE: Asthma and Allergy Foundation of America Partners with AHIP’s Coalition for Medicare Choices to Create New Respiratory-Focused Patient Education Resources Landover, M.D. June 6, 2016: Today, the Asthma and Allergy Foundation (AAFA) unveiled new resources created in collaboration with America’s Health Insurance Plans (AHIP) Coalition for Medicare Choices (CMC). Throughout May, which was Asthma and Allergy Awareness month, AAFA worked with the CMC’s Medicare Advantage...
These are just a few things we were able to do this year for the asthma and allergy community because of you. But there is more for us to do to significantly reduce the burden of these diseases on people with asthma and allergies. And we can with your help.
Q: Is it common for asthma to develop very suddenly? I am a 30-year-old, Caucasian female and I have had intermittent shortness of breath for 11 months, but have had everyday attacks for the past 3 months. My allergist and pulmonologist are having a hard time managing my asthma.
The Asthma and Allergy Foundation of America will recap some of the top research on allergies and asthma every quarter. Here is a look at studies reported between April and June 2017. Learn why some children may not respond to asthma treatments, how testosterone may affect asthma and more.
The Asthma and Allergy Foundation of America will recap some of the top research about allergies and asthma every three months. Here is a look at studies reported between January and March. Read about how treating homes for cockroaches can improve children's asthma, a possible link between insomnia and developing asthma, the safety of allergy immunotherapy and more.
Living in a food desert – an urban area where it is difficult to buy affordable or good-quality fresh food – means you’re at increased risk to have asthma. Children who were studied who did not have access to fresh fruits and vegetables had higher rates of asthma than children who did have access.
U.S. Senator Tom Carper (D-Del.), top Democrat on the U.S. Senate Environment and Public Works Committee, was joined by 32 Senators in introducing legislation that would put the United States on a path to achieve net-zero greenhouse gas emissions by no later than 2050.
Could drones be used someday to deliver life-saving medications or interventions in the case of a child’s emergency, a drug overdose or in response to a mass casualty scene? According to new research presented at the American Academy of Pediatrics 2019 National Conference & Exhibition, it’s an idea worth exploring.
The Asthma and Allergy Foundation of America (AAFA) has been fighting to save lives for nearly 70 years. With your support, we provide education, conduct patient-centered research and advocate for protections for our community. Our experience and strong community ties allowed us to take prompt action on the COVID-19 crisis . Thanks to your generous support, we are leading the fight against COVID-19 for people with asthma and allergies. But we need your help to continue to provide COVID-19...
Representatives Eliot L. Engel (D-NY-16), Fred Upton (R-MI-06), Pete King (R-NY-02) and TJ Cox (D-CA-21), all members of the House Asthma and Allergy Caucus, have introduced legislation to honor Elijah E. Cummings’ long-time advocacy for those living with asthma. The Elijah E. Cummings Family Asthma Act would expand federal, state, and local efforts to improve care for individuals with asthma.
The FDA has approved another biologic treatment, Dupixent, for the treatment of both moderate and severe asthma patients with eosinophilic phenotype
and oral corticosteroid-dependent asthma, regardless of phenotype.
The U.S. Food and Drug Administration today approved the first generic of Advair Diskus (fluticasone propionate and salmeterol inhalation powder) for the twice-daily treatment of asthma in patients aged four years and older and maintenance treatment of airflow obstruction and reducing exacerbations in patients with chronic obstructive pulmonary disease (COPD).
The U.S. Food and Drug Administration today approved the first generic version of EpiPen and EpiPen Jr (epinephrine) auto-injector for the emergency treatment of allergic reactions, including those that are life-threatening (anaphylaxis), in adults and pediatric patients who weigh more than 33 pounds. Teva Pharmaceuticals USA gained approval to market its generic epinephrine auto-injector in 0.3 mg and 0.15 mg strengths.
The U.S. Food and Drug Administration today approved the first generic of ProAir HFA (albuterol sulfate) Inhalation Aerosol for the treatment or prevention of bronchospasm in patients four years of age and older with reversible obstructive airway disease and the prevention of exercise-induced bronchospasm in patients four years of age and older.
[Press Release] Teva Announces FDA Approval of Two New RespiClick® Maintenance Inhalers for the Treatment of Asthma Approvals Expand Portfolio of Respiratory Medicines Delivered in RespiClick® Inhaler Designed to Eliminate the Need for Hand-Breath Coordination During Inhalation JERUSALEM--(BUSINESS WIRE)--Teva Pharmaceutical Industries Ltd., (NYSE and TASE: TEVA) announced that the U.S. Food and Drug Administration (FDA) approved two products for adolescent and adult patients with asthma.
Genentech, a member of the Roche Group, announced that the U.S. Food and Drug Administration (FDA) has accepted the company’s supplemental Biologics License Application (sBLA) for Xolair® (omalizumab) for the treatment of nasal polyps in adult patients 18 years of age and older with inadequate response to intranasal corticosteroids.
June is National Healthy Homes Month. Your home can have a big impact on how well you manage your asthma and allergies. Reducing asthma triggers and allergens in your home should be an important part of your asthma and allergy management plan.
Researchers estimate the number of people with food allergies in the U.S. to be 32 million. It breaks down to 6 million children and 26 million adults – more than previously thought. 1 It is common for food allergies to develop in childhood, but you can develop a food allergy at any age. Adults are more likely to develop allergies to crustacean shellfish (like crabs, lobster or shrimp), peanuts, milk, tree nuts and fin fish. 1 Adult-onset food allergies are generally life-long and are not...
A U.S. Housing and Urban Development (HUD) ban on smoking in public housing starts July 31, 2018. According to the rule, no one can smoke inside public housing. They also cannot smoke within 25 feet of any public housing building.
We know that children with pollen food allergy syndrome (PFAS) also suffer from seasonal allergies. A new study being presented at the American College of Allergy, Asthma and Immunology (ACAAI) Annual Scientific Meeting in Houston shows that allergy shots (subcutaneous immunotherapy) can be effective in reducing PFAS symptoms for pediatric patients.
In a joint effort to educate consumers about bedroom allergies and allergen-reduction solutions, Protect-A-Bed and the Asthma and Allergy Foundation of America (AAFA) have partnered on a national campaign to raise awareness of household allergens.
[Press Release] Roe, Hoyer Introduce School-Based Respiratory Health Management Act Washington, May 2, 2017 | Lani Short (202-225-6356) WASHINGTON, DC – Today, Rep. Phil Roe, M.D. (R-TN) and House Democratic Whip Steny H. Hoyer (D-MD) introduced H.R. 2285, the School-Based Respiratory Health Management Act, legislation that encourages states to help ensure students with reversible lower airway disorders, such as asthma, have assistance at school with managing their chronic disease and can...
Welcome to our first monthly advocacy update. My name is Jenna Riemenschneider, Director of Advocacy at the Asthma and Allergy Foundation of America (AAFA). I'm pictured above with Mark Vieth, Senior Vice President at Cavarocchi Ruscio Dennis Associates, at a meeting with Airlines for America.
Through this monthly blog series, I will update you on our advocacy efforts. We have already had a busy fall. This first post will include our September and October activity.
Students in a New Jersey modeling club showed off more than just fashion on the runway last month. The fashion show happened to fall during Asthma and Allergy Awareness Month. So the children at the Robert J. Fulton School in North Bergen decided to donate the show's ticket sales to the Asthma and Allergy Foundation of America . The school is in a densely populated, urban area near New York City. The students chose AAFA since so many kids have asthma and food allergies. The club for seventh...
Genentech, a member of the Roche Group, today announced that the Phase III CAPSTONE-2 study assessing the safety and efficacy of baloxavir marboxil in people at high risk of complications from the flu met the study’s primary objective, and showed superior efficacy in the primary endpoint of time to improvement of influenza symptoms versus placebo.
Alpha-gal syndrome (AGS), a food allergy commonly known as red meat allergy, may develop from ticks’ saliva itself, whether a tick has fed on another animal before biting a human or not. This news comes from a study presented for the first time at the 2019 Annual Meeting of the American Academy of Allergy, Asthma & Immunology.
A study presented at the American College of Allergy, Asthma and Immunology (ACAAI) Annual Scientific Meeting found adolescents with asthma were twice as likely to smoke as kids without asthma. And they continue to smoke well into their teen years, even though they know smoking is particularly bad for their lungs.
Teva Pharmaceutical Industries Ltd. announced that the U.S. Food and Drug Administration (FDA) has approved ProAir ® Digihaler™ (albuterol sulfate 117 mcg) inhalation powder, the first and only digital inhaler with built-in sensors which connects to a companion mobile application and provides inhaler use information to people with asthma and COPD. Learn more.
[Press Release] Teva Launches AirDuo™ RespiClick® and its Authorized Generic, Two Inhalers Containing Fluticasone Propionate and Salmeterol First and Only Generic Fluticasone Propionate and Salmeterol (ICS/LABA) Inhaler Available in the U.S. JERUSALEM, April 20, 2017 – Teva Pharmaceutical Industries Ltd., (NYSE and TASE: TEVA) today announced the simultaneous launch of AirDuo™ RespiClick® (fluticasone propionate and salmeterol) inhalation powder and its authorized generic for the treatment...
Earlier this year, we asked you to tell us about your life with asthma in our My Life With Asthma online survey. Your responses gave us insight into your unique experiences with asthma.
Asthma is a chronic condition that can be different for each person. This means there is no “one size fits all” approach to managing asthma. Many people manage it well with the right treatment. But 5 to 10 percent have trouble even on maximum treatment. These people have severe asthma.
When you hear about medical research, you probably hear about an organization called the NIH. The NIH is the United States’ medical research agency. It is also one of the top medical research agencies in the world.
Novartis today announced topline results from its pivotal global Phase III LUSTER-11 and LUSTER-22 studies exploring the efficacy and safety of the investigational oral, once-daily, DP2 receptor antagonist fevipiprant (QAW039). The pooled analyses of the LUSTER trials did not meet3 the clinically relevant threshold for reduction in rate of moderate-to-severe exacerbation compared to placebo over a 52-week treatment period for either of the doses (150mg / 450 mg).
More than 10 years ago, U.S. tobacco companies were ordered to run ads about the bad effects of tobacco products. On Nov. 26, 2017, the court-ordered ads began. Tobacco smoke can cause a lot of damage to your health, even if you aren’t the one smoking. In 2006, a court found several major tobacco companies guilty of misleading the public about the dangers of tobacco products. The companies are finally running ads in major newspapers and on TV stations. These ads have to include specific...
[Press Release] Mylan Launches the First Generic for EpiPen® (epinephrine injection, USP) Auto-Injector as an Authorized Generic Authorized Generic Offered at More Than 50% Below Wholesale Acquisition Cost of EpiPen Auto-Injector HERTFORDSHIRE, England and PITTSBURGH, Dec. 16, 2016 / PRNewswire / -- Mylan N.V. (NASDAQ, TASE: MYL) today announced the launch of the authorized generic for EpiPen ® (epinephrine injection, USP) Auto-Injector at a wholesale acquisition cost (WAC) of $300 per...
If you think only infants suffer from eczema, think again. The uncomfortable, itchy rash that most people relate to babies and young children occurs frequently in adults. Although many adults with atopic dermatitis (commonly known as eczema) develop the disease in childhood and carry it through life, a large number are first diagnosed in adulthood – a trend being discussed at the American College of Allergy, Asthma and Immunology (ACAAI) Annual Scientific Meeting.
AAFA is dedicated to keeping infants and children with food allergies safe and healthy until a cure is found. AAFA is proud to have participated in the NIAID Expert Panel and Coordinating Committee to help develop the Addendum Guidelines for the prevention of peanut allergy.
The New York City Council is considering the Asthma-Free Housing Act of 2015 We know the environment can play a strong role in our health. But for patients with chronic conditions like asthma, a healthy indoor setting is critical. Indoor health hazards can all be asthma triggers . These hazards include mold, dust and pests (cockroaches, dust mites). Healthy indoor settings are a vital part of managing and controlling asthma. In large urban cities, older buildings and housing issues can often...
When you block a person, they can no longer invite you to a private message or post to your profile wall. Replies and comments they make will be collapsed/hidden by default. Finally, you'll never receive email notifications about content they create or likes they designate for your content.
Note: if you proceed, you will no longer be following .